{"nct_id":"NCT01763164","title":"Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma","status":"COMPLETED","status_verified_date":"2021-03","start_date":"2013-07-12","start_date_type":"ACTUAL","primary_completion_date":"2015-12-01","primary_completion_date_type":"ACTUAL","completion_date":"2019-06-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}